Report Shows Insurance Coverage of Biomarker Testing Has Not Kept Up With Innovation
September 30, 2020
September 30, 2020
CHICAGO, Illinois, Sept. 30 -- The LUNGevity Foundation issued the following news release on Sept. 29:
LUNGevity Foundation, the nation's premier lung cancer-focused nonprofit organization, in partnership with the American Cancer Society Cancer Action Network (ACS CAN), issued a report today analyzing private payer health insurance coverage of biomarker testing for non-small cell lung, colorectal, breast, and prostate cancers. The study serves as an update to a similar review of hea . . .
LUNGevity Foundation, the nation's premier lung cancer-focused nonprofit organization, in partnership with the American Cancer Society Cancer Action Network (ACS CAN), issued a report today analyzing private payer health insurance coverage of biomarker testing for non-small cell lung, colorectal, breast, and prostate cancers. The study serves as an update to a similar review of hea . . .